Latest Breaking News On - Alnylam pharmaceuticals nasdaq - Page 1 : comparemela.com

Alnylam Issues 2023 Corporate Responsibility Report

Alnylam Issues 2023 Corporate Responsibility Report
marketscreener.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from marketscreener.com Daily Mail and Mail on Sunday newspapers.

United kingdomYvonne greenstreetAlnylam pharmaceuticals nasdaqAlnylam pharmaceuticals incAlnylam pharmaceuticalsBeacon of hope initiativeChief executive officerNovartis led beaconHope initiativeHistorically black collegesAlnylam challengersResponsibility reportNobel prize winning

Medison Pharma ("Medison"), a global pharma company focused on providing access to highly innovative therapies for patients in international markets, and Alnylam Pharmaceuticals, Inc. (Nasdaq: ALNY), the …

United statesUnited kingdomNorton oliveiraGil gurfinkelMedison pharmaMeir jakobsohnAsia pacificMedison pharma inbal chenAlnylam pharmaceuticals nasdaqRegional partnership in europeGlobal commercial communicationsCorporate communicationsAlnylam pharmaceuticals sara guzzone fallonAlnylam pharmaceuticals incAlnylam pharmaceuticals announce expansionMulti regional partnership

Alnylam to Webcast Conference Call Discussing First Quarter 2024 Financial Results

Alnylam Pharmaceuticals, Inc. , the leading RNAi therapeutics company, announced today that it will report financial results for the first quarter ending March 31, 2024 on Thursday, May 2, 2024,.

United kingdomAlnylam pharmaceuticals incAlnylam pharmaceuticalsAlnylam pharmaceuticals nasdaqNobel prize winning

Alnylam Presents Positive Results from the KARDIA-2 Phase 2 Study of Zilebesiran Added to Standard of Care Antihypertensives in Patients with Inadequately Controlled Hypertension

CAMBRIDGE, Mass. (BUSINESS WIRE) Apr 7, 2024

United kingdomUnited statesChristine regan lindenboomJosh brodskyAkshay desaiSimon foxAlnylam pharmaceuticalsHealth promotion seriesZilebesiran program lead at alnylamWorld health organizationJournal of the american college cardiologySecurities exchangeAmerican college of cardiologyExchange commissionAlnylam pharmaceuticals nasdaqHeart failure program

Alnylam Launches Hereditary ATTR (hATTR) Amyloidosis Campaign to Help Shorten Time to Diagnosis for Inherited and Rapidly Progressive Disease

Alnylam Launches Hereditary ATTR (hATTR) Amyloidosis Campaign to Help Shorten Time to Diagnosis for Inherited and Rapidly Progressive Disease
marketscreener.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from marketscreener.com Daily Mail and Mail on Sunday newspapers.

United kingdomBernice bennettTiffany patrickAlnylam pharmaceuticals incAlnylam pharmaceuticalsAlnylam pharmaceuticals nasdaqFamily health history road tripBusiness wireVice presidentPatient advocacyNobel prize winning